Document Detail


VIP binding sites on synaptosomes from rat cerebral cortex: structure-binding relationship.
MedLine Citation:
PMID:  3018696     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The structural requirements for VIP interaction with receptors on synaptosomes from rat cerebral cortex was investigated by the ability of VIP and VIP fragments, secretin analogues and fragments, peptides of the VIP/secretin family and several other regulatory peptides to inhibit specific 125I-VIP binding. Only large VIP fragments interacted with the VIP receptors with potencies relative to VIP ranging from 0.9-0.006%. The rank order of inhibition was: VIP 7-27 greater than VIP 11-28 greater than VIP 1-22-NH2 greater than VIP 16-28. Shorter fragments: VIP 18-28; VIP 18-28-NH2; VIP 19-28; VIP 21-28; VIP 22-28; VIP 1-18; VIP 1-18-NH2; VIP 1-10-NH2; VIP 1-6; VIP 16-20 and VIP 16-19 had no effect. Secretin fragments and analogues inhibited 125I-VIP binding with potencies of 2.2-0.01% relative to VIP in the order; secretin greater than (Ala4, Val5) secretin greater than (D-Ala4) secretin greater than (D-Phe6) secretin greater than secretin 5-27 greater than secretin 14-27. Other peptides of the VIP/secretin family inhibited 125I-VIP binding with potencies of 200-1%; avian VIP greater than porcine VIP greater than PHI = secretin greater than human GRF, whereas glucagon and GIP showed no inhibition. Among twenty-five other regulatory peptides only avian PP and somatostatin were inhibitors with relative potencies of 0.02% and 0.03%, respectively. In conclusion it may be emphasized that the intact VIP molecule is essential for VIP interaction with its receptors in the rat brain cortex.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
P Staun-Olsen; B Ottesen; S Gammeltoft; J Fahrenkrug
Related Documents :
24162846 - A directional switch of integrin signalling and a new anti-thrombotic strategy.
2853556 - Receptor autoradiographical evidence of a preferential reduction of binding sites for a...
1764066 - Functional expression of transcobalamin ii cdna in xenopus laevis oocytes.
8512616 - Protein modifications in the d2 protein of photosystem ii affect properties of the qb/h...
23665916 - C/ebp maintains chromatin accessibility in liver and facilitates glucocorticoid recepto...
17015906 - 11c-jhu75528: a radiotracer for pet imaging of cb1 cannabinoid receptors.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Peptides     Volume:  7 Suppl 1     ISSN:  0196-9781     ISO Abbreviation:  Peptides     Publication Date:  1986  
Date Detail:
Created Date:  1986-10-23     Completed Date:  1986-10-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8008690     Medline TA:  Peptides     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  181-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Binding, Competitive
Cerebral Cortex / metabolism*
Female
Peptide Fragments / metabolism
Rats
Rats, Inbred Strains
Receptors, Cell Surface / metabolism*
Receptors, Vasoactive Intestinal Peptide
Secretin / analogs & derivatives,  metabolism
Structure-Activity Relationship
Synaptosomes / metabolism
Vasoactive Intestinal Peptide / analogs & derivatives,  metabolism*
Chemical
Reg. No./Substance:
0/Peptide Fragments; 0/Receptors, Cell Surface; 0/Receptors, Vasoactive Intestinal Peptide; 1393-25-5/Secretin; 37221-79-7/Vasoactive Intestinal Peptide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis.
Next Document:  Vasoactive intestinal peptide actions on cyclic AMP levels in cultured striatal neurons.